Similar articles

• Extracorporeal treatment of erythrocytes in sickle cell anemia: hemoglobin carbamylation.

  Diederich D, Curran M, Odenbaugh A, Diederich A, Core E. Diederich D, et al. Tex Rep Biol Med. 1980-1981;40:313-22. Tex Rep Biol Med. 1980. PMID: 7323976 No abstract available.
• New Approaches to the therapy of sickle cell disease.

  Luskey KL, Schechter AN, Hercules JI. Luskey KL, et al. Tex Rep Biol Med. 1980-1981;40:305-12. Tex Rep Biol Med. 1980. PMID: 6172868 Review. No abstract available.
• The increasing complexity of sickle cell anemia.

  Warth JA, Rucknagel DL. Warth JA, et al. Prog Hematol. 1983;13:25-47. Prog Hematol. 1983. PMID: 6199811 Review. No abstract available.
• Hematology clinic. Sickle cell disease.

  Ngo D, Steinberg M. Ngo D, et al. Hematology. 2014 Jun;19(4):244-5. doi: 10.1179/1024533214Z.000000000276. Epub 2014 Mar 26. Hematology. 2014. PMID: 24666152 No abstract available.
• Measurements of red cell deformability and hydration reflect HbF and HbA₂ in blood from patients with sickle cell anemia.

  Parrow NL, Tu H, Nichols J, Violet PC, Pittman CA, Fitzhugh C, Fleming RE, Mohandas N, Tisdale JF, Levine M. Parrow NL, et al. Blood Cells Mol Dis. 2017 Jun;65:41-50. doi: 10.1016/j.bcmd.2017.04.005. Epub 2017 Apr 18. Blood Cells Mol Dis. 2017. PMID: 28472705